Quote For Bioniche Life Sciences Inc. BNC.TO
Bioniche Life Sciences Inc. (BNC.TO) (Toronto Stock Exchange)
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
$0.43
3 Dec 2009
+4.94%
$0.43
--
75,200
$0.43
$0.41
$0.75
$0.30
0.52
94,165
News
Press Releases
No news stories for this company within the last 30 days.
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| McRae, Graeme | Chairman of the Board, President, Chief Executive Officer | 377,549 |
| Ford, Brian | Chief Financial Officer | -- |
| Beraldo, Albert | Director; President of Alveda Pharmaceuticals Inc. | -- |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $30.58 |
| Shares Outstanding (Mil.) | 71.96 |
| Float (Mil.) | 63.27 |
| Dividend Information | |
|---|---|
| Yield % | -- |
| Annual Dividend ($ CAD) | 0.00 |
| Payout Ratio(TTM) % | -- |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.66 |
| Current Ratio | 2.90 |
| LT Debt/Equity | 92.71 |
| Total Debt/Equity | 154.55 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | -- |
| Price/Sales(TTM) | 0.95 |
| Price/Book(TTM) | 12.31 |
| Price/Cash Flow(TTM) | -- |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $-0.20 |
| Sales(TTM) | $0.45 |
| Book Value(MRQ) | $0.03 |
| Cash Flow(TTM) | $-0.16 |
| Cash(MRQ) | $0.19 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | -311.51 |
| Return on Assets(TTM) | -36.19 |
| Return on Investment(TTM) | -49.57 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 57.08 |
| Operating Margin(TTM) % | -41.89 |
| Profit Margin(TTM) % | -43.22 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
